McMullin, Mary FrancesJames, GlenDuncombe, Andrew S.de Vocht, FrankFritschi, LinClarke, MikeAnderson, Lesley A.2020-04-152020-04-152016-05-26McMullin, M F, James, G, Duncombe, A S, de Vocht, F, Fritschi, L, Clarke, M & Anderson, L A 2016, 'Patient perspectives of a diagnosis of myeloproliferative neoplasm in a case control study', Experimental Hematology and Oncology, vol. 5, no. 1, 14. https://doi.org/10.1186/s40164-016-0043-42162-3619ORCID: /0000-0002-1000-3649/work/72175516https://hdl.handle.net/2164/14083Acknowledgements We thank all the participants who contributed to the study. The work was supported by Queen’s University Belfast’s Centre for Public Health. The MOSAICC Study team acknowledges the support of the National Institute for Health Research, through the Northern Ireland Cancer Research Network (NICRN) and for Southampton the Central South Coast Cancer Network (CSCCN). The MOSAICC Study team also acknowledges the support of research nurses Emma Gaunt of Southampton and Claire Leathem of Belfast. The interpretation and reporting of these data are the sole responsibility of the authors. GJ is a Ph.D. candidate at Queen’s University Belfast supported by funding from MPN Voice.5767668engSDG 3 - Good Health and Well-beingCase-control studyClassificationMyeloproliferative neoplasmsPatient perceptionRC0254 Neoplasms. Tumors. Oncology (including Cancer)HematologyOncologyCancer ResearchRC0254Journal article10.1186/s40164-016-0043-4http://www.scopus.com/inward/record.url?scp=84978025211&partnerID=8YFLogxK51